- POSITIVE
Quarterly Revenue Xylem Jun-2026 Quarterly Revenue is $2,336 Million which is growth of 1.5% YoY.
- POSITIVE
Quarterly Net Profit Xylem Jun-2026 Quarterly Net Profit is $263 Million which is growth of 16.4% YoY.
101.82-2.75(-2.63%)
2.5M
XNYS Volume
XNYS 07 Oct, 2026 5:30 PM (EDT)
Xylem quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Forecaster Analyst Estimates for Xylem share price target, revenues, EPS, net income and more
Xylem quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Rev. | 2,336 | 2,125 | 2,397 | 2,268 | 2,301 | 2,069 | 2,256 | 2,104 | 2,169 | 2,033 | 2,118 | 2,076 | 1,722 | |
Cost Of Rev. | 1,373 | 1,322 | 1,465 | 1,385 | 1,409 | 1,301 | 1,399 | 1,320 | 1,350 | 1,281 | 1,362 | 1,312 | 1,071 | |
Gross Profit | 963 | 803 | 932 | 883 | 892 | 768 | 857 | 784 | 819 | 752 | 756 | 764 | 651 | |
| 562 | 528 | 546 | 526 | 561 | 516 | 565 | 500 | 543 | 533 | 526 | 552 | 504 | ||
Operating Profit | 401 | 275 | 386 | 357 | 331 | 252 | 292 | 284 | 276 | 219 | 230 | 212 | 147 | |
| -7 | -4 | 21 | -6 | -9 | -8 | 19 | -10 | -11 | -14 | 14 | -14 | -12 | ||
Profit Before Tax | 364 | 244 | 368 | 297 | 299 | 217 | 375 | 269 | 247 | 196 | 210 | 185 | 114 | |
Tax | 103 | 55 | 35 | 71 | 75 | 50 | 49 | 52 | 53 | 43 | -56 | 33 | 22 | |
| 263 | 193 | 335 | 227 | 226 | 169 | 326 | 217 | 194 | 153 | 266 | 152 | 92 | ||
Diluted NI Avail to Com Stockholders Ann. | 263 | 193 | 335 | 227 | 226 | 169 | 326 | 217 | 194 | 153 | 266 | 152 | 92 | |
Basic EPS | 1.1 | 0.8 | 1.4 | 0.9 | 0.9 | 0.7 | 1.3 | 0.9 | 0.8 | 0.6 | 1.2 | 0.6 | 0.5 | |
Diluted EPS After ExtraOrdinary | 1.2 | 0.9 | 1.4 | 1.1 | 1 | 0.8 | 1.6 | 0.9 | 0.9 | 0.7 | 1.2 | 0.7 | 0.6 | |
Number Of Shares End | 236.3 | 242.8 | 243.6 | 243.5 | 243.4 | 243.1 | 242.9 | 242.9 | 242.6 | 241.9 | 241.2 | 240.9 | 205.5 | |
Net Income Continuing Discontinued Operations | 263 | 193 | 335 | 227 | 226 | 169 | 326 | 217 | 194 | 153 | 266 | 152 | 92 | |
Normalized Income | 282.4 | 214 | 350.4 | 272.7 | 245.5 | 192.8 | 382.5 | 221.8 | 211.3 | 164.7 | 281.8 | 169.3 | 114.7 | |
Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Interest | 7 | 4 | 6 | 6 | 9 | 8 | 9 | 10 | 11 | 14 | 14 | 14 | 12 | |
Net Interest Income | -7 | -4 | 21 | -6 | -9 | -8 | 19 | -10 | -11 | -14 | 14 | -14 | -12 | |
EBIT | 371 | 248 | 374 | 303 | 308 | 225 | 384 | 279 | 258 | 210 | 224 | 199 | 126 | |
EBITDA | 511 | 388 | 517 | 445 | 453 | 370 | 526 | 420 | 403 | 344 | 361 | 346 | 218 | |
Reconciled Cost Of Rev. | 1,373 | 1,322 | 1,465 | 1,385 | 1,409 | 1,301 | 1,399 | 1,320 | 1,350 | 1,281 | 1,362 | 1,312 | 1,071 | |
Reconciled Depr. | 140 | 140 | 143 | 142 | 145 | 145 | 142 | 141 | 145 | 134 | 137 | 147 | 92 | |
Profit From Continuing Operations | 261 | 189 | 333 | 222 | 226 | 169 | 326 | 217 | 194 | 153 | 266 | 152 | 92 | |
Normalized EBITDA | 538 | 415 | 534 | 505 | 479 | 401 | 591 | 426 | 425 | 359 | 381 | 367 | 246 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Xylem competitor comparison and performance snapshot within industry
Xylem annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Xylem Dec-2025 Annual Revenue is $9,035 Million which is growth of 5.5% YoY.
- POSITIVE
Annual Net Profit Xylem Dec-2025 Annual Net Profit is $957 Million which is growth of 7.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | TTM | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17.8% | 13.1% | 9,035 | 8,562 | 7,364 | 5,522 | 5,195 | 4,876 | 5,249 | 5,207 | 4,707 | 3,771 | 3,653 | |||
Cost Of Rev. Ann. | 17.4% | 12.8% | 5,545 | 5,560 | 5,350 | 4,647 | 3,438 | 3,220 | 3,046 | 3,203 | 3,181 | 2,856 | 2,310 | 2,249 | |
Gross Profit Ann. | 18.6% | 13.7% | 3,581 | 3,475 | 3,212 | 2,717 | 2,084 | 1,975 | 1,830 | 2,046 | 2,026 | 1,851 | 1,461 | 1,404 | |
Operating Exp. Ann. | 14.5% | 10.1% | 2,162 | 2,149 | 2,141 | 1,989 | 1,433 | 1,383 | 1,330 | 1,349 | 1,350 | 1,270 | 1,025 | 949 | |
Operating Profit Ann. | 26.8% | 21.5% | 1,419 | 1,326 | 1,071 | 728 | 651 | 592 | 500 | 697 | 676 | 581 | 436 | 455 | |
- | - | 4 | -2 | -16 | -21 | -34 | -69 | -70 | -62 | -78 | -79 | -68 | -53 | ||
Other Exp. Ann. | - | - | -143 | 32 | -72 | -177 | -12 | -145 | -219 | -13 | -36 | -28 | 1 | ||
PBT Ann. | 39% | 32.9% | 1,273 | 1,181 | 1,087 | 635 | 440 | 511 | 285 | 416 | 585 | 466 | 340 | 403 | |
Tax Ann. | 39.6% | 49.4% | 264 | 231 | 197 | 26 | 85 | 84 | 31 | 15 | 36 | 136 | 80 | 63 | |
39.2% | 30.4% | 1,018 | 957 | 890 | 609 | 355 | 427 | 254 | 401 | 549 | 331 | 260 | 340 | ||
Diluted NI Avail to Com Stockholders Ann. | 39.2% | 30.4% | 1,018 | 957 | 890 | 609 | 355 | 427 | 254 | 401 | 549 | 331 | 260 | 340 | |
EPS Ann. | 24.9% | 22.7% | 3.9 | 3.7 | 2.8 | 2 | 2.4 | 1.4 | 2.2 | 3.1 | 1.8 | 1.5 | 1.9 | ||
Diluted EPS Ann. | 24.9% | 22.7% | 3.9 | 3.7 | 2.8 | 2 | 2.4 | 1.4 | 2.2 | 3 | 1.8 | 1.5 | 1.9 | ||
Number Of Shares End | 10.6% | 6.2% | 243.6 | 242.9 | 241.2 | 180.3 | 180.4 | 180.1 | 180.3 | 179.8 | 179.6 | 179.4 | 179.1 | ||
Total Exp. Ann. | 16.5% | 12% | 7,709 | 7,491 | 6,636 | 4,871 | 4,603 | 4,376 | 4,552 | 4,531 | 4,126 | 3,335 | 3,198 | ||
Net Income Continuing Discontinued Operations Ann. | 39.2% | 30.4% | 1,018 | 957 | 890 | 609 | 355 | 427 | 254 | 401 | 549 | 331 | 260 | 340 | |
Normalized Income Ann. | 41.3% | 23.4% | 1,119.4 | 1,064.9 | 978.5 | 682.8 | 377.6 | 431.2 | 372.5 | 603.2 | 569.7 | 355.8 | 283 | 337.5 | |
Interest Income Ann. | 19.1% | 31% | 27 | 28 | 28 | 16 | 7 | 7 | 5 | 4 | 3 | 2 | 2 | ||
Interest Ann. | -16.6% | -17.7% | 23 | 29 | 44 | 49 | 50 | 76 | 77 | 67 | 82 | 82 | 70 | 55 | |
EBITDA Ann. | 35% | 23.8% | 1,861 | 1,785 | 1,693 | 1,120 | 726 | 832 | 613 | 740 | 928 | 782 | 561 | 591 | |
Reconciled Cost Of Rev. Ann. | 17.4% | 12.8% | 5,545 | 5,560 | 5,350 | 4,647 | 3,438 | 3,220 | 3,046 | 3,203 | 3,181 | 2,856 | 2,310 | 2,249 | |
Reconciled Depr. Ann. | 34.6% | 18% | 565 | 575 | 562 | 436 | 236 | 245 | 251 | 257 | 261 | 234 | 151 | 133 | |
Profit From Continuing Operations Ann. | 38.8% | 30.2% | 1,005 | 950 | 890 | 609 | 355 | 427 | 254 | 401 | 549 | 330 | 260 | 340 | |
Normalized EBITDA Ann. | 36.5% | 20.8% | 1,992 | 1,919 | 1,801 | 1,197 | 754 | 837 | 746 | 950 | 950 | 817 | 591 | 588 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
5.5%
2Y CAGR
10.8%
3Y CAGR
17.8%
5Y CAGR
13.1%
7Y CAGR
8.2%
10Y CAGR
9.5%
Total Revenue Annual growth is lower than historical averages.
Net Profit Ann.
1Y CHG
7.5%
2Y CAGR
25.4%
3Y CAGR
39.2%
5Y CAGR
30.4%
7Y CAGR
8.3%
10Y CAGR
10.9%
Net Profit Annual growth is lower than historical averages.
Operating Exp. Ann.
1Y CHG
0.4%
2Y CAGR
3.9%
3Y CAGR
14.5%
5Y CAGR
10.1%
7Y CAGR
6.9%
10Y CAGR
8.5%
Operating Expenses Annual Cr growth is lower than historical averages.
Xylem balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Xylem Dec-2025 Total Shareholders Fund is $11,480 Million which is growth of 7.9% YoY.
- POSITIVE
Total Assets Xylem Dec-2025 Total Assets is $17,634 Million which is growth of 6.9% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
30.4% | 15% | 17,634 | 16,493 | 16,112 | 7,952 | 8,276 | 8,750 | 7,710 | 7,222 | 6,860 | 6,474 | 4,657 | ||
9.8% | 0.4% | 5,885 | 5,611 | 5,936 | 4,449 | 5,050 | 5,774 | 4,743 | 4,440 | 4,341 | 4,267 | 2,573 | ||
48.7% | 31.1% | 11,480 | 10,642 | 10,166 | 3,494 | 3,218 | 2,968 | 2,957 | 2,768 | 2,503 | 2,190 | 2,084 | ||
Total Capitalization Ann. | 33.9% | 18.8% | 12,888 | 12,620 | 12,434 | 5,374 | 5,658 | 5,452 | 4,997 | 4,819 | 4,703 | 4,298 | 3,280 | |
Tangible Assets Ann. | - | - | 876 | 283 | 50 | -155 | -590 | -979 | -1,056 | -1,440 | -1,433 | -1,643 | 65 | |
Working Capital Ann. | 7.9% | 2.6% | 1,785 | 1,762 | 1,679 | 1,422 | 1,769 | 1,567 | 949 | 705 | 971 | 601 | 1,182 | |
Invested Capital Ann. | 35.7% | 17.3% | 13,422 | 12,658 | 12,450 | 5,374 | 5,658 | 6,052 | 5,273 | 5,076 | 4,703 | 4,558 | 3,358 | |
Tangible Book Value Ann. | - | - | 876 | 283 | 50 | -155 | -590 | -979 | -1,056 | -1,440 | -1,433 | -1,643 | 65 | |
Borrowings Ann. | 1.9% | -8.1% | 2,063 | 2,125 | 2,390 | 1,949 | 2,509 | 3,147 | 2,377 | 2,308 | 2,200 | 2,368 | 1,274 | |
Net Debt Ann. | -20.9% | -17.5% | 463 | 895 | 1,265 | 936 | 1,091 | 1,209 | 1,592 | 2,012 | 1,786 | 2,060 | 594 | |
Share Issued Ann. | 9.9% | 5.9% | 259.9 | 259.2 | 257.6 | 196 | 195.6 | 194.9 | 193.9 | 192.9 | 192.3 | 191.4 | 190.2 | |
Number Of Shares End | 10.6% | 6.2% | 243.6 | 242.9 | 241.2 | 180.3 | 180.4 | 180.1 | 180.3 | 179.8 | 179.6 | 179.4 | 179.1 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
6.9%
2Y CAGR
4.6%
3Y CAGR
30.4%
5Y CAGR
15%
7Y CAGR
13.6%
10Y CAGR
14.2%
Total Assets Annual growth is lower than historical averages.
Total Current Liabilities Ann.
1Y CHG
22.3%
2Y CAGR
13.8%
3Y CAGR
21.6%
5Y CAGR
7.9%
7Y CAGR
10.8%
10Y CAGR
13.2%
Total Current Liabilities Annual Cr growth is higher than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
7.9%
2Y CAGR
6.3%
3Y CAGR
48.7%
5Y CAGR
31.1%
7Y CAGR
22.5%
10Y CAGR
18.6%
Total ShareHolders Funds Annual growth is lower than historical averages.
Xylem ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Book Value Per Share Xylem Book Value Per Share is $45 which is growth of -1.9% YoY.
- NEUTRAL
ROE Xylem ROE is 0% which is growth of 0% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RoA Ann. % | - | - | - | 5.46% | 5.06% | 4.38% | 5.02% | 3.09% | 5.37% | 7.80% | 4.96% | 4.67% | 7.14% | |
ROE Ann. % | - | - | - | 8.55% | 8.92% | 10.58% | 13.81% | 8.57% | 14.01% | 20.83% | 14.11% | 12.17% | 16.15% | |
ROIC % | - | - | - | 2.6 | 2.2 | 2.9 | 2.2 | 2.8 | 2.4 | 4.7 | 1.8 | 1.6 | 3.8 | |
OPM Ann. % | 7.6% | 7.4% | 14.68% | 12.51% | 9.89% | 11.79% | 11.40% | 10.25% | 13.28% | 12.98% | 12.34% | 11.56% | 12.46% | |
Inventory Turnover Ratio Ann. | - | - | - | 5.3 | 5.1 | 4.6 | 5.1 | 5.6 | 5.7 | 5.7 | 5.5 | 4.8 | 4.9 | |
Asset Turnover Ann. % | - | - | - | 0.5 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
Working Capital Turnover Ann. | 9.4% | 10.5% | 5.1 | 4.9 | 4.4 | 3.9 | 2.9 | 3.1 | 5.5 | 7.4 | 4.9 | 6.3 | 3.1 | |
Quick Ratio Ann. | - | - | - | 1.2 | 1.2 | 1.3 | 1.7 | 1.4 | 1.2 | 1 | 1.3 | 0.9 | 1.7 | |
Current Ratio Ann. | - | - | - | 1.8 | 1.8 | 1.9 | 2.3 | 1.8 | 1.6 | 1.5 | 1.9 | 1.5 | 2.4 | |
Interest Coverage Ratio Ann. | - | - | - | 25.7 | 14 | 9.8 | 7.7 | 4.7 | 7.2 | 8.1 | 6.7 | 5.9 | 8.3 | |
LT Debt To Equity Ann. | - | - | - | 0.2 | 0.2 | 0.5 | 0.8 | 0.8 | 0.7 | 0.7 | 0.9 | 1 | 0.6 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Xylem cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Xylem Dec-2025 Cash From Operating Activity is $1,241 Million which is growth of -1.7% YoY.
- POSITIVE
Net Cash Flow Xylem Dec-2025 Net Cash Flow is $269 Million which is growth of 62.0% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
27.7% | 8.5% | 1,241 | 1,263 | 837 | 596 | 538 | 824 | 839 | 586 | 686 | 497 | 464 | ||
- | - | -471 | -482 | -628 | -191 | -183 | -169 | -231 | -643 | -181 | -1,886 | -132 | ||
- | - | -501 | -615 | -157 | -790 | -855 | 473 | -177 | -40 | -421 | 1,034 | -262 | ||
Cash Plus Cash Eqv. End Of Year Ann. | 16.1% | -4.6% | 1,479 | 1,121 | 1,019 | 944 | 1,349 | 1,875 | 724 | 296 | 414 | 308 | 680 | |
Net Increase In Cash Plus Cash Eqv.s Ann. | - | -24.9% | 269 | 166 | 52 | -385 | -500 | 1,128 | 431 | -97 | 84 | -355 | 70 | |
Cash Plus Cash Eqv. Begin Of Year Ann. | -6% | 9.1% | 1,121 | 1,019 | 944 | 1,349 | 1,875 | 724 | 296 | 414 | 308 | 680 | 663 | |
Income Tax Paid Supplemental Data Ann. | 43.2% | 45.5% | 267 | 219 | 211 | 91 | 83 | 41 | 107 | 75 | 57 | 78 | 75 | |
Interest Paid Supplemental Data Ann. | -7.1% | -4.6% | 61 | 67 | 69 | 76 | 99 | 77 | 77 | 78 | 78 | 49 | 52 | |
Capex Ann. | - | - | -331 | -321 | -271 | -208 | -208 | -183 | -226 | -237 | -170 | -124 | -117 | |
Issuance Of Capital Stock Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Issuance Of Debt Ann. | - | -76.3% | 1 | 1 | 278 | 1,344 | 281 | 336 | 1,814 | - | ||||
Repayment Of Debt Ann. | - | - | -82 | -285 | -160 | -527 | -600 | -640 | -254 | -172 | -282 | -688 | -3 | |
Repurchase Of Capital Stock Ann. | - | - | -15 | -20 | -25 | -52 | -68 | -61 | -40 | -59 | -25 | -4 | -179 | |
Free Cash Flow Ann. | 32.9% | 7.3% | 910 | 942 | 566 | 388 | 330 | 641 | 613 | 349 | 516 | 373 | 347 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-1.7%
2Y CAGR
21.8%
3Y CAGR
27.7%
5Y CAGR
8.5%
7Y CAGR
11.3%
10Y CAGR
10.3%
Cash from Operating Activity Annual is falling faster than historical averages.
